Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Citius Pharmaceuticals Inc (NQ: CTXR ) 0.5950 +0.0217 (+3.79%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Citius Pharmaceuticals Inc Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL) July 18, 2024 Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second... Via Newsfile Exposures Product Safety Analysts Hunt for Undervalued Biotech Stocks July 17, 2024 Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com, a go-to investing platform releases the first... Via Newsfile Topics Economy Initial Public Offering Exposures Interest Rates Securities Market Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval July 17, 2024 Via AB Newswire Bloodstream Infections - From Threats to Solutions July 11, 2024 Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the second... Via Newsfile Topics Death Exposures Death Citius Pharmaceuticals (NASDAQ: CTXR) Spearheads the Global Cancer Immunotherapy Market May 07, 2022 Via Get News Exposures Product Safety Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024 July 11, 2024 Via AB Newswire Exposures Product Safety Biopharma Stocks Transformative Innovation for the Future of Health July 11, 2024 Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first... Via Newsfile Topics Artificial Intelligence Exposures Artificial Intelligence Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Featured in Coverage of the EF Hutton Annual Global Conference May 16, 2024 Via Investor Brand Network Exposures Product Safety Sidoti Events, LLC’s Virtual November Micro-Cap Conference November 14, 2023 Via ACCESSWIRE Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is Specializing in Stem Cell Therapy & Critical Cancer Care Immunotherapy May 11, 2022 Via Get News Exposures Product Safety Citius Pharmaceuticals, Inc is helping Global Cancer Immunotherapy to reach the Market Cap of 152 Billion by 2024. May 04, 2022 Via AB Newswire Exposures Product Safety Biotechs Zero in on Growing Ovarian Cancer Market as Pivotal Trials Advance Through Regulatory Agencies May 03, 2021 Via FinancialNewsMedia Topics Death Exposures Death Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.